Prednisolone for the first rhinovirus-induced wheezing and 4-year asthma risk: A randomized trial.

Annamari KoistinenMinna LukkarinenRiitta TurunenTytti VuorinenTero VahlbergCarlos A CamargoJames GernOlli RuuskanenTuomas Jartti

Published in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (2017)

Overall, prednisolone did not affect the time to initiation of asthma control medication when compared to placebo. However, prednisolone may be beneficial in first-time wheezing children whose episode was severe and associated with high rhinovirus load. (ClinicalTrials.gov, NCT00731575).

Keyphrases

chronic obstructive pulmonary disease
lung function
allergic rhinitis
high glucose
drug induced
young adults
healthcare
diabetic rats
early onset
cystic fibrosis
emergency department
air pollution
oxidative stress
adverse drug
phase iii